Susquehanna International Group
DMAC icon

Susquehanna International Group’s DiaMedica Therapeutics DMAC Stock Holding History

Susquehanna International Group’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$147K Sell
21,650
-22,736
-51% -$180K ﹤0.01% 12033
2025
Q4 		$353K Buy
44,386
+16,019
+56% +$120K ﹤0.01% 9564
2025
Q3 		$195K Sell
28,367
-4,429
-14% -$24K ﹤0.01% 11024
2025
Q2 		$128K Sell
32,796
-523,797
-94% -$2.04M ﹤0.01% 11623
2025
Q1 		$2.11M Buy
556,593
+181,748
+48% +$1.04M ﹤0.01% 5414
2024
Q4 		$2.04M Buy
374,845
+273,395
+269% +$1.29M ﹤0.01% 5277
2024
Q3 		$425K Buy
101,450
+58,077
+134% +$214K ﹤0.01% 8861
2024
Q2 		$128K Sell
43,373
-165,959
-79% -$455K ﹤0.01% 10845
2024
Q1 		$580K Buy
209,332
+181,713
+658% +$528K ﹤0.01% 8151
2023
Q4 		$78.4K Buy
+27,619
New +$68.3K ﹤0.01% 11489
2023
Q3 		– Sell
-16,923
Closed -$73.1K – 12181
2023
Q2 		$73.1K Buy
+16,923
New +$41.1K ﹤0.01% 11152
2022
Q4 		– Sell
-35,258
Closed -$44K – 12663
2022
Q3 		$44K Buy
+35,258
New +$55.1K ﹤0.01% 12279
2022
Q2 		– Sell
-16,324
Closed -$38.1K – 13075
2022
Q1 		$41K Buy
16,324
+2,259
+16% +$6.41K ﹤0.01% 12391
2021
Q4 		$52K Sell
14,065
-46,364
-77% -$182K ﹤0.01% 12521
2021
Q3 		$242K Buy
60,429
+13,264
+28% +$50.8K ﹤0.01% 11076
2021
Q2 		$210K Buy
+47,165
New +$387K ﹤0.01% 11504

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's DMAC Position: Q1 2026 in Review

Susquehanna International Group reduced its DiaMedica Therapeutics (DMAC) stake by 51% in Q1 2026, selling an estimated $180K and leaving 21,650 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #12033.

Susquehanna International Group first reported a position in DMAC in Q2 2021 and has held it in 16 quarters since. The position peaked at $2.11M in Q1 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Susquehanna International Group held 21,650 shares of DiaMedica Therapeutics worth $147K as of Q1 2026.
  • Susquehanna International Group sold 22,736 DiaMedica Therapeutics shares in Q1 2026, an estimated $180K.
  • DiaMedica Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12033 holding.
  • Susquehanna International Group first reported a position in DiaMedica Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's DiaMedica Therapeutics position peaked at $2.11M in Q1 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.